Careers  |  Sign In  |  Register

Latest in Resource Center: Macular Degeneration: Latest News

By Will Boggs, MD NEW YORK (Reuters Health) - An individualized approach to treatment offers the best outcomes for patients with wet age-related macular degeneration (wAMD), according to a new review of the literature. "The theoretical advantages of tailored therapies for neovascular AMD are to avoid over-...
By Julie Steenhuysen (Reuters) - An artificial implant that performs some functions of the retina and helps restore sight to people with retinitis pigmentosa won U.S. marketing approval, the Food and Drug Administration said on Thursday. The device called Argus II is made by privately held Second Sight...
By David Douglas NEW YORK (Reuters Health) - In patients receiving ranibizumab for subfoveal neovascular age-related macular degeneration (AMD), a 0.5 mg monthly dose provides the most favorable results, according to findings from the phase III HARBOR study. Dr. Brandon G. Busbee of Tennessee Retina,...
123